Castelluccia Alessandra, Sardaro Angela, Niccoli Asabella Artor, Pisani Antonio Rosario, Rubini Dino, Portaluri Maurizio, Tramacere Francesco
Department of Radiotherapy "A. Perrino" Hospital Brindisi Italy.
Section of Radiology and Radiation Oncology, Interdisciplinary Department of Medicine University of Bari "Aldo Moro" Bari Italy.
Clin Case Rep. 2024 Apr 5;12(4):e8633. doi: 10.1002/ccr3.8633. eCollection 2024 Apr.
PET-driven SBRT plus pembrolizumab as first-line therapy against pleomorphic Pancoast cancer appears beneficial, probably due to high equivalent doses of SBRT on photopenic necrotic core and synergic immune system stimulation of immunoradiotherapy.
正电子发射断层扫描(PET)引导下的立体定向体部放疗(SBRT)联合帕博利珠单抗作为一线治疗多形性肺上沟癌似乎有益,这可能是由于SBRT在放射性坏死核心上的等效剂量较高以及免疫放疗对免疫系统的协同刺激作用。